GlassScriptPhysician profile
Grace Fairley Hampton
NPI 1639634751
$3,621.79
in general payments reported to CMS, 2019-2025
25 companies · $1,214 in 2025
The $1,214 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $435 · 2023: $798 · 2024: $1,174 · 2025: $1,214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,186.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $724.33 | 2022-2025 | Lifevest |
| Abbott Laboratories | $721.56 | 2023-2025 | Gallant, Assurity, Esprit |
| Merck Sharp & Dohme LLC | $456.84 | 2022-2025 | Verquvo |
| Abiomed | $284.57 | 2022-2025 | Impella |
| Cvrx, INC. | $251.05 | 2023-2025 | Barostim Neo System |
| Boston Scientific Corporation | $248.78 | 2023-2025 | Emblem Mri S-Icd, Eluvia, Watchman Access System |
| Janssen Pharmaceuticals, INC | $126.25 | 2022-2024 | Xarelto |
| Angiodynamics, INC. | $121.57 | 2022 | |
| Novartis Pharmaceuticals Corporation | $96.20 | 2024 | |
| Bard Peripheral Vascular, INC. | $85.73 | 2022-2023 | Rotarexs 6 F X 135 Cm |
| Inspire Medical Systems, INC. | $69.75 | 2024-2025 | Inspire |
| E.R. Squibb & Sons, L.L.C. | $61.28 | 2022-2023 | Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $58.92 | 2022-2024 | |
| Lexicon Pharmaceuticals, INC. | $48.42 | 2023-2024 | Inpefa |
| Philips North America LLC | $44.41 | 2023-2025 | Ambulatory Monitoring & Diagnostics Undivided |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.69 | 2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $33.45 | 2022-2023 | Farxiga |
| Scpharmaceuticals INC. | $28.91 | 2023-2024 | |
| Cardiva Medical, INC. | $24.70 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Alnylam Pharmaceuticals INC. | $18.19 | 2025 | Amvuttra |
| Lemaitre Vascular, INC. | $17.80 | 2023 | Artegraft Vascular Graft |
| Medline Industries LP | $17.56 | 2024 | |
| Shockwave Medical, INC | $16.00 | 2022 | |
| Pfizer INC. | $15.56 | 2025 | |
| Amgen INC. | $11.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Hampton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.